Tadashi Osaki Selected Research

Cytostatic Agents

3/2002

Construction and analysis of new vector systems with improved interleukin-18 secretion in a xenogeneic human tumor model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tadashi Osaki Research Topics

Disease

11	Neoplasms (Cancer) 08/2011 - 03/2002
8	Lung Neoplasms (Lung Cancer) 10/2008 - 02/2003
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2013 - 01/2007
3	Malignant Mesothelioma 08/2011 - 09/2006
3	Fibrosis (Cirrhosis) 03/2006 - 07/2002
2	Pneumonia (Pneumonitis) 03/2012 - 05/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2008 - 03/2006
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2006 - 02/2003
2	Erythema 09/2004 - 01/2004
1	Fever (Fevers) 03/2012
1	Inflammation (Inflammations) 03/2012
1	Atherosclerosis 01/2011
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 01/2007
1	Mesothelioma 09/2006
1	Asthma (Bronchial Asthma) 03/2006
1	Granuloma 08/2005
1	Leukopenia 09/2004
1	Leukemia 09/2004
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2004
1	Idiopathic Pulmonary Fibrosis 02/2004
1	Infections 02/2004
1	Breast Neoplasms (Breast Cancer) 01/2004
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2003
1	Autoimmune Diseases (Autoimmune Disease) 12/2003
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2003
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2002
1	Cachexia 07/2002
1	Colonic Neoplasms (Colon Cancer) 03/2002

Drug/Important Bio-Agent (IBA)

5	TetraspaninsIBA 05/2009 - 02/2003
4	Interleukin-18 (Interleukin 18)IBA 01/2011 - 03/2002
4	CytokinesIBA 01/2011 - 07/2002
3	AntigensIBA 04/2010 - 01/2004
3	WT1 ProteinsIBA 04/2010 - 01/2004
3	Tumor Biomarkers (Tumor Markers)IBA 10/2008 - 01/2004
3	Gefitinib (Iressa)FDA Link 03/2007 - 04/2006
3	ErbB Receptors (EGF Receptor)IBA 03/2007 - 04/2006
3	Proteins (Proteins, Gene)FDA Link 10/2006 - 08/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2013 - 01/2010
2	Carboplatin (JM8)FDA LinkGeneric 01/2013 - 01/2010
2	InterleukinsIBA 01/2011 - 03/2002
2	Tyrosine Kinase InhibitorsIBA 01/2007 - 09/2006
2	IntegrinsIBA 10/2006 - 02/2003
2	Protein Subunit VaccinesIBA 04/2006 - 09/2004
2	Peptides (Polypeptides)IBA 09/2004 - 01/2004
2	VaccinesIBA 09/2004 - 01/2004
1	Gemcitabine FDA Link 01/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2012
1	Dietary Fats (Dietary Fat)IBA 01/2011
1	LipopolysaccharidesIBA 05/2009
1	Complementary DNA (cDNA)IBA 10/2008
1	flt3 ligand protein (flt3 ligand)IBA 10/2008
1	MesothelinIBA 10/2008
1	AsbestosIBA 10/2008
1	Peptide Hydrolases (Proteases)FDA Link 09/2008
1	Phosphotransferases (Kinase)IBA 03/2007
1	Small Interfering RNA (siRNA)IBA 10/2006
1	Pharmaceutical PreparationsIBA 10/2006
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2006
1	Extracellular Matrix ProteinsIBA 10/2006
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2006
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 10/2006
1	ErbB-2 ReceptorIBA 09/2006
1	titanium silicide (TS-1)IBA 08/2006
1	Oxycodone (Oxycontin)FDA LinkGeneric 08/2006
1	Cancer VaccinesIBA 04/2006
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2006
1	Theophylline (Theon)FDA LinkGeneric 03/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2005
1	Surface-Active Agents (Surfactants)IBA 02/2004
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2004
1	ImmunosorbentsIBA 02/2004
1	E-SelectinIBA 02/2004
1	SelectinsIBA 02/2004
1	Biological ProductsIBA 02/2004
1	EnzymesIBA 02/2004
1	Apoprotein(a) (Apolipoprotein (a))IBA 02/2004
1	C-Reactive ProteinIBA 02/2004
1	Monatide (IMS 3015)IBA 01/2004
1	Sialyl Lewis X AntigenIBA 01/2004
1	HLA-A Antigens (HLA-A)IBA 01/2004
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2004
1	Interleukin-6 (Interleukin 6)IBA 05/2003
1	Integrin beta1IBA 02/2003
1	Bleomycin (Blenoxane)FDA LinkGeneric 07/2002
1	p38 Mitogen-Activated Protein KinasesIBA 07/2002
1	indium-bleomycinIBA 07/2002
1	Cytostatic AgentsIBA 03/2002

Therapy/Procedure

4	Therapeutics 01/2013 - 04/2006
3	Immunotherapy 04/2010 - 01/2004
1	Maintenance Chemotherapy 01/2013
1	General Anesthesia 03/2012
1	Combination Drug Therapy (Combination Chemotherapy) 01/2010
1	Intravenous Injections 08/2005
1	Intraperitoneal Injections 03/2002